Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXCALIBUR1+2: Treatment for Colorectal Liver Metastases With Heavy Tumour Burden
NCT04898504Phase 2Terminated
- Sponsor
- Oslo University Hospital
- Start
- Aug 2021
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of floxuridine in colorectal liver metastases (CRLM), sponsored by Oslo University Hospital. Started Aug 2021; status: terminated.
02
Drugs
floxuridine
03
Conditions
colorectal liver metastases (CRLM)
Beyond the preview
Go deeper on NCT04898504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04898504.